Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

TherapeuticsMD, Inc. (TXMD)

9.29   0.39 (4.38%) 08-07 23:45
Open: 8.76 Pre. Close: 8.9
High: 9.39 Low: 8.61
Volume: 170,703 Market Cap: 87(M)
TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17Ăź-estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system. Its preclinical projects include the development of TX-005HR, a progesterone-alone transdermal cream; TX-006HR, an estradiol and progesterone transdermal cream; TX-007HR and TX-008HR, which are transdermal patch product candidates; and TX-009HR, an oral progesterone and estradiol formulation. It also manufactures and distributes branded and generic prescription prenatal vitamins under the vitaTrue, vitaPearl, vitaMedMD, and BocaGreenMD Prena1 brands. The company sells its prescription pharmaceutical products and prenatal vitamin products to wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 9.4 - 9.44 9.44 - 9.46
Low: 8.52 - 8.56 8.56 - 8.6
Close: 9.22 - 9.29 9.29 - 9.35

Technical analysis

as of: 2022-08-05 4:26:00 PM
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 11.68     One year: 13.64
Support: Support1: 6.31    Support2: 4.03
Resistance: Resistance1: 10    Resistance2: 11.68
Pivot: 6.84
Moving Average: MA(5): 9     MA(20): 6.75
MA(100): 9.99     MA(250): 19.79
MACD: MACD(12,26): 0.1     Signal(9): -0.4
Stochastic oscillator: %K(14,3): 84.6     %D(3): 86.1
RSI: RSI(14): 61.3
52-week: High: 43.5  Low: 0.56
Average Vol(K): 3-Month: 1,536 (K)  10-Days: 992 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ TXMD ] has closed below upper band by 12.3%. Bollinger Bands are 13.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Mon, 01 Aug 2022
Healthcare Stocks Moving Monday: OTRK, AEMD, TXMD, GOVX, KZIA, BGXX, IMAB, TRHC - InvestorsObserver

Mon, 01 Aug 2022
Analyst Rating: Will TherapeuticsMD Inc (TXMD) Stock Lead the Market? - InvestorsObserver

Fri, 29 Jul 2022
Premarket Mover: TherapeuticsMD Inc (TXMD) Up 2.00% - InvestorsObserver

Thu, 28 Jul 2022
Healthcare Stocks on the Move Thursday: BTTX, ARDS, TXMD, GOVX, BHC, CYH, LXRX, TDOC - InvestorsObserver

Tue, 19 Jul 2022
TXMD stock jumps as top investor discloses insider purchase (NASDAQ:TXMD) - Seeking Alpha

Wed, 13 Jul 2022
Pre-Open Movers: ironSource Surges on Buyback, Tech Stocks Fall on Hot CPI -

Financial Analysis

Price to Book Value: Underperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Outperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Underperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Drug Manufacturers—Specialty & Generic
Shares Out. 9 (M)
Shares Float 7 (M)
% Held by Insiders 12 (%)
% Held by Institutions 35.7 (%)
Shares Short 401 (K)
Shares Short P.Month 2,010 (K)

Stock Financials

EPS -21.73
EPS Est Next Qtl -0.11
EPS Est This Year -0.44
EPS Est Next Year -0.34
Book Value (p.s.) -16.22
Profit Margin (%) -210.7
Operating Margin (%) -143.9
Return on Assets (ttm) -41.8
Return on Equity (ttm) 0
Qtrly Rev. Growth -2.8
Gross Profit (p.s.) 7.73
Sales Per Share 9.8
EBITDA (p.s.) -13.64
Qtrly Earnings Growth 0
Operating Cash Flow -134 (M)
Levered Free Cash Flow -62 (M)

Stock Valuations

PE Ratio -0.43
PEG Ratio -0.1
Price to Book value -0.58
Price to Sales 0.94
Price to Cash Flow -0.62

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.